Clinical Trial Update: Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection [Phase 2]

View source ↗

Summary

Phase 2 study evaluating inhaled SNG001 for viral pneumonia in mechanically ventilated patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Viral Pneumonia

Drugs mentioned

• SNG001 (Interferon beta-1a (inhaled formulation))

Snippet

Sponsor: Synairgen Research Ltd. | Conditions: Viral Pneumonia | Phase 2 | Status: RECRUITING